Durable Recombinant 2019-ncov S1 Protein (his Tag)(d614g)(active) Stored At 4-8℃ Flash Sale: 30% Off [nx836yuv]

Recombinant 2019-nCoV S1 Protein (His Tag)(D614G)(Active)

Our Recombinant 2019-nCoV S1 Protein (His Tag)(D614G)(Active) is a cutting-edge research tool designed for various applications in virology and immunology. This protein is derived from the spike (S) glycoprotein of SARS-CoV-2, which is a key component in the viral entry process. The His Tag and D614G mutation enhance protein stability and binding affinity, making it an ideal choice for researchers seeking to understand the molecular mechanisms of COVID-19 infection.

Product Properties and Specifications

This recombinant protein is expressed in HEK293 cells and is purified to a purity of greater than 90% as determined by reducing SDS-PAGE. It has a calculated molecular weight of 76.4 kDa and is tagged with a C-His tag, which aids in protein detection and purification. The protein has been demonstrated to have high bio-activity, with an EC50 of 350-650 ng/mL when bound to Recombinant Human ACE2 Protein (mFc Tag)(Active). The protein is stored at 4-8℃ and is supplied as a lyophilized powder, which is stable for up to 12 months when stored at -20 to -80℃. Below is a list of key properties and specifications:

• Purity: > 90% as determined by reducing SDS-PAGE
• Endotoxin: < 1.0 EU per μg of the protein as determined by the LAL method
• Storage: Lyophilized powder, stable for up to 12 months at -20 to -80℃; reconstituted protein solution stable at 4-8℃ for 2-7 days
• Shipping: Supplied with ice packs for safe transport

Practical Applications and Benefits

The Recombinant 2019-nCoV S1 Protein (His Tag)(D614G)(Active) is a versatile research tool with a wide range of applications. It can be used to study the interaction between the spike protein and host cell receptors, assess the efficacy of potential antiviral compounds, and develop vaccines against COVID-19. This protein is particularly beneficial for researchers in the following scenarios:

• Investigating the molecular basis of SARS-CoV-2 infection
• Designing and testing antiviral drugs
• Developing vaccines and immunotherapies
• Screening for potential therapeutic targets

With its high purity, bio-activity, and stability, this protein is an essential tool for advancing our understanding of COVID-19 and developing effective treatments and vaccines.